Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ananda, Aum, First Wave, Lobe, Nova Mentis, Regeneron, Sensorion, Transcode, Vistagen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Egg Medical, Electromed, Pulmonx, Surgibox, Treace Medical Concepts.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Ascletis, Buchang, Capstone, Caribou, Genentech, Gilead, Kala, Novavax, Remd, Sofie.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Clarity, Immorna, Innocare, Junshi, Revive, Takeda, Triastek.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Nanovibronix, Neurologica.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Ascletis, Biocryst, Biomarin, Blueprint, BMS, Contrafect, Crinetics, CSL, Diamyd, Enlivex, Everest, Exscientia, Gilead, GSK, Junshi, Kintara, Mabwell, Molecure, Opiant, Pacylex, Revive, Roche, Sarepta, Spectrum, Spectrumx, Tenaya.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anteris, Seekin.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Empatica, Lucira Health.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Argenx, Gamida, GSK, Innocare, Intelgenx, Junshi, Marker, Palisade, Regeneron, Revive, Takeda.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABVC, Akeso, Amarin, Ascletis, Astrazeneca, Beigene, Canbridge, Daiichi Sankyo, Everest Medicines, Gmax, Junshi, Novavax, Nuance.